Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 2011. The report details a specific corporate action regarding the repurchase and cancellation of the company's ordinary shares, executed under shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on share repurchase activity and capital structure updates.
- Shares Purchased: 910,000 ordinary shares of 25 pence each.
- Transaction Date: August 16, 2011.
- Price Range: Highest price paid was 1,284.5 pence per share; lowest price paid was 1,272.5 pence per share.
- Treasury Shares Held: 502,996,816 shares (representing 8.99% of total issued share capital and 9.88% of total voting rights).
- Shares in Issue: 5,090,839,261 shares (excluding Treasury shares).
Material Changes
The primary material change reported is the reduction of the company's issued share capital through the cancellation of 910,000 repurchased shares. Consequently, the number of shares held in Treasury increased to 502,996,816. The filing does not provide comparative data against a prior period for financial performance.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It includes a standard disclaimer stating that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Key Facts for Investor Verification
- Verify the total cost of the 910,000 share repurchase based on the disclosed price range (1,272.5 to 1,284.5 pence).
- Confirm the updated total issued share capital and the specific percentage of voting rights held in Treasury (9.88%).
- Check subsequent filings for the impact of this share cancellation on earnings per share (EPS) calculations.
- Note that the 5,090,839,261 shares in issue serve as the denominator for shareholder notification thresholds under Disclosure and Transparency Rules.